By February 1, 2024, all study team members will be required to have their CV's and CITI training linked to their IRBNet User Profile. Please reach out to HRPP and IRB Staff if you need assistance. (Only Baystate Health CITI Training will be accepted. CV's should be signed, dated and under three years old.)
It is the study team's responsibility to close a study in OnCore when they submit the closure report to the IRB. IRB Analysts are unable to complete their tasks in OnCore until the study is closed.
Coming Soon...
A revised informed consent template will be introduced in the coming weeks. The IRB Office will require the use of this template when submitting new studies.
Also, be on the lookout for a revised human research determination worksheet.
THANK YOU!
The Importance of Clinical Trial Transparency and FDA Oversight
Biomedical and healthcare progress is dependent upon research that informs our decisions. The clinical trial is the most reliable method to determine the benefits and risks of interventions. The formation of ClinicalTrials.gov in February 2000 was a major step forward by providing a public record of trials.
OHRP's Research Community Forum: Curating Connection (April 2024)
Curating Connection Objectives
Explore the convergence and intersectionality of industry trends, flexibility, and regulatory compliance with a focus on vulnerable populations.
Discuss opportunities for collaborative and innovative approaches on policy, practice, and implementation throughout key areas of Human Research Protection Programs and with community partners.
Underscore cohesive and insightful best practices in support of future focused advancement and translational research while fostering avenues for connection and engagement within our local communities.
